Cargando…
Abnormal mRNA Expression Levels of Telomere-Binding Proteins Represent Biomarkers in Myelodysplastic Syndromes: A Case-Control Study
OBJECTIVE: As evidence was shown that abnormal shortening of telomeres begins to accumulate in myelodysplastic syndrome (MDS) patients, this study was conducted to determine the relationship between the mRNA expression levels of telomere-binding proteins (TRF1/TRF2/TIN2/TPP1/POT1/RAP1) and the risk...
Autores principales: | Liu, Baoshan, Yan, Rongdi, Zhang, Jie, Wang, Bin, Sun, Hu, Cui, Xing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Galenos Publishing
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5544038/ https://www.ncbi.nlm.nih.gov/pubmed/28404540 http://dx.doi.org/10.4274/tjh.2016.0364 |
Ejemplares similares
-
Abnormal Ferroptosis in Myelodysplastic Syndrome
por: Lv, Qi, et al.
Publicado: (2020) -
MYBL2 mRNA expression as a potential biomarker of therapeutic response to genotoxic treatments in myelodysplastic syndrome
por: Bayley, Rachel, et al.
Publicado: (2018) -
Poly (ADP-ribose) polymerase 1 mRNA levels strongly correlate with the prognosis of myelodysplastic syndromes
por: Diamantopoulos, P, et al.
Publicado: (2017) -
Telomere integrated scoring system of myelodysplastic syndrome
por: Park, Hee Sue, et al.
Publicado: (2023) -
The importance of critically short telomere in myelodysplastic syndrome
por: Shin, Dong-Yeop, et al.
Publicado: (2022)